Recent studies have shown that the action of regulatory factors such as P53, FLIPs, IAPs, and members of the Bcl-2 family members may promote apoptosis through other regulatory factors, pathways, enzymes, or increased drug sensitivity in cancer cells. This evidence concerns the gene BCL2 and cancer.